Literature DB >> 2418943

Development of adenocarcinomas in the stomach.

T Hattori.   

Abstract

To elucidate the histogenesis of gastric adenocarcinomas, the author looked for smaller carcinomas, and studied their histologic features and the histologic characteristics of the neighboring gastric mucosa. In 325 resected stomachs, 27 microcarcinomas, including initial lesions, were detected. Most of them were typical adenocarcinomas, whose histologic features were different from those of dysplasias. The gastric mucosa around the microcarcinomas was mostly intestinalized. However, the smaller the carcinomas, the less complete was the form of intestinal metaplasia, and the metaplasia was under progression in many gastric tubules. The smallest carcinomas consisted of a few, newly formed glandular complexes, confined to the neck region of the tubules, whereas the upper and the lower part of the tubules were still lined by normal gastric cells. The smallest dysplasia was an in situ lesion, also confined to the neck region of the tubules. These findings indicate that a starting point of adenocarcinomas and dysplasias is in the proliferative cell zone at the neck region. Intestinal metaplasia, dysplasia, and adenocarcinoma arise coincidentally. This implies that no precursor is present for each of them. It appears that most adenocarcinomas arise in gastric tubules when an abnormal differentiation is induced in stem cells after intestinal metaplasia. They are not a consequence of dysplasia, but share a common origin with it.

Entities:  

Mesh:

Year:  1986        PMID: 2418943     DOI: 10.1002/1097-0142(19860415)57:8<1528::aid-cncr2820570815>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  46 in total

Review 1.  Oxyntic atrophy, metaplasia, and gastric cancer.

Authors:  James R Goldenring; Ki Taek Nam
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

2.  Changing the natural history of metachronous gastric cancer after H. pylori eradication.

Authors:  David Y Graham; Satoko Matsueda; Akiko Shiotani
Journal:  Jpn J Helicobacter Res       Date:  2015

3.  Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract.

Authors:  A E Berstad; P Brandtzaeg
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

4.  Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow up study.

Authors:  A Kokkola; R Haapiainen; F Laxén; P Puolakkainen; E Kivilaakso; J Virtamo; P Sipponen
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

5.  Is intestinal metaplasia a risk for gastric carcinoma?

Authors:  P Sossai; R Cielo; R Barbazza
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

6.  Identification of alanyl aminopeptidase (CD13) as a surface marker for isolation of mature gastric zymogenic chief cells.

Authors:  Benjamin D Moore; Ramon U Jin; Luciana Osaki; Judith Romero-Gallo; Jennifer Noto; Richard M Peek; Jason C Mills
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-29       Impact factor: 4.052

7.  Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.

Authors:  Ki Taek Nam; Hyuk-Joon Lee; Hoyin Mok; Judith Romero-Gallo; James E Crowe; Richard M Peek; James R Goldenring
Journal:  Gastroenterology       Date:  2008-12-13       Impact factor: 22.682

8.  General features of gastric carcinomas and comparison of HSP70 and NK cell immunoreactivity with prognostic factors.

Authors:  Ozlem Canöz; Olcay Belenli; Tahír E Patiroglu
Journal:  Pathol Oncol Res       Date:  2003-02-11       Impact factor: 3.201

9.  Gastric carcinogenesis.

Authors:  Ismail Gomceli; Baris Demiriz; Mesut Tez
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

10.  Effects of ezrin knockdown on the structure of gastric glandular epithelia.

Authors:  Saori Yoshida; Hiroto Yamamoto; Takahito Tetsui; Yuka Kobayakawa; Ryo Hatano; Ken-ichi Mukaisho; Takanori Hattori; Hiroyuki Sugihara; Shinji Asano
Journal:  J Physiol Sci       Date:  2015-09-02       Impact factor: 2.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.